Welcome to our dedicated page for Curtiss Wright SEC filings (Ticker: CW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Curtiss-Wright Corporation (NYSE: CW) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Curtiss-Wright is a global integrated business that supplies highly engineered products, solutions and services mainly to aerospace and defense markets, and critical technologies in commercial nuclear power, process and industrial markets. Its filings offer detailed insight into how these activities translate into financial results, risks and capital allocation decisions.
Through periodic reports such as Form 10-K and Form 10-Q, Curtiss-Wright presents segment information for Aerospace & Industrial, Defense Electronics, and Naval & Power, along with discussions of total aerospace and defense markets and total commercial markets. These documents typically include data on sales, operating income, operating margin, new orders, backlog and free cash flow, as well as commentary on factors such as product mix, restructuring initiatives and operational excellence programs.
Current reports on Form 8-K provide updates on specific events, including quarterly and annual earnings releases, changes to financial guidance, adoption of Rule 10b5-1 trading plans for share repurchases, and expansions of repurchase authorizations. These filings describe how Curtiss-Wright structures its repurchase programs, the amounts authorized, and the expected timing of purchases under those plans.
Stock Titan enhances access to these filings with AI-powered summaries that highlight key points from lengthy documents, helping users quickly understand segment performance, capital allocation actions and notable risk disclosures. Real-time updates from EDGAR, along with visibility into relevant forms such as 10-K, 10-Q and 8-K, allow investors and researchers to review Curtiss-Wright’s regulatory history and ongoing reporting in a structured, easy-to-navigate format.
Curtiss-Wright executive George P. McDonald reported an equity award and corrected his share count. He received a grant of 304 time-based restricted stock units under the 2024 Omnibus Incentive Plan, each representing one share of common stock, which will cliff vest after a three-year period from the March 9, 2026 grant date.
The filing also corrects his previously reported common stock ownership, noting that 2,064 shares acquired through employee benefit transactions before he became an executive officer were inadvertently omitted from his earlier Form 3. Following these updates, he directly holds 4,011 shares of common stock and 1,462 restricted stock units, including dividend credits on prior grants.
Rayment Kevin reported acquisition or exercise transactions in this Form 4 filing.
Curtiss-Wright Executive VP and COO Kevin Rayment received a grant of 652 time-based restricted stock units under the company’s 2024 Omnibus Incentive Plan. Each unit represents a contingent right to one share of common stock and will cliff vest after a three-year period from the March 9, 2026 grant date.
The units were granted as an employee benefit with no purchase price, and Rayment’s total reported restricted stock unit balance after this award is 6,432 units, which includes dividend credits earned on prior grants.
Farkas K Christopher reported acquisition or exercise transactions in this Form 4 filing.
Curtiss-Wright Executive VP and CFO K. Christopher Farkas received a grant of 645 restricted stock units (RSUs) on March 9, 2026. These RSUs were granted as an employee benefit under the company’s 2024 Omnibus Incentive Plan and carry no purchase price.
Each RSU represents a contingent right to receive one share of Curtiss-Wright common stock, with the award cliff vesting after a three-year period from the grant date. Following this grant, Farkas holds 11,549 RSUs in total, a figure that also reflects dividend credits earned on prior outstanding grants.
Bamford Lynn M reported acquisition or exercise transactions in this Form 4 filing.
Curtiss-Wright Corp reported that Chair and CEO Lynn M. Bamford received a grant of 2,735 time-based restricted stock units (RSUs) under the company’s 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of common stock.
The RSUs will cliff vest after a three-year vesting period from the March 9, 2026 grant date, aligning the award with longer-term performance. The grant was made as an employee benefit with no cash price on the grant date. Following this award, Bamford directly holds 22,281 shares and RSUs, a figure that includes dividend credits earned on prior grants.
Curtiss-Wright Corporation’s Executive VP and CFO, K. Christopher Farkas, reported an open-market sale of 3,105 shares of common stock at an average price of $694.51 per share. The sale was executed under a pre-arranged Rule 10b5-1 trading plan and in line with company share ownership guidelines. Following this transaction, he directly holds 4,253 shares of Curtiss-Wright common stock.
The issuer filed a Form 144 disclosing proposed sales of Common stock totaling 3,105 shares tied to a performance share vesting event dated 02/03/2026, with UBS Financial Services Inc. listed as broker. The filing also reports prior dispositions by K. Christopher Farkas: 5,047 shares on 11/11/2025 for $2,916,721.36 and 2,665 shares on 02/04/2026 for $1,669,034.61.
Curtiss-Wright Corporation filed its annual report describing a diversified, engineering-focused portfolio serving aerospace, defense, naval, nuclear power, and industrial markets. The company operates through three segments: Aerospace & Industrial, Defense Electronics, and Naval & Power, with a growing emphasis on its Pivot to Growth strategy.
Government-related business is a key driver: sales to the U.S. Government and foreign government end use represented 58% of 2025 total net sales, with U.S. Government sales of $1,647,019,000. Backlog was about $4.1 billion, supporting future revenue visibility. Foreign operations contributed 41% of pre-tax earnings in 2025, and about 27% of total net sales came from customers outside the U.S.
The company ended 2025 with roughly 9,100 employees in more than 20 countries and emphasizes culture, safety, and talent development. Safety metrics improved modestly, with TRR of 1.22 and DART of 0.71. Curtiss-Wright also highlights key risks, including heavy defense exposure, complex government regulations, cybersecurity threats, acquisition execution, climate and ESG pressures, and financial risks tied to $2.2 billion of goodwill and about $1.0 billion of debt.
Curtiss-Wright reported record fourth-quarter and full-year 2025 results with strong growth in sales, earnings, and cash flow. For Q4 2025, sales were $947 million, up 15%, and adjusted diluted EPS was $3.79, up 16%. Full-year 2025 sales reached $3.5 billion, up 12%, with adjusted operating income of $651 million, up 19%, and adjusted EPS of $13.23, up 21%. Free cash flow was $554 million, a 15% increase with 111% conversion, while new orders of $4.1 billion and backlog of $4.1 billion each rose 10% and 18%, respectively. The company repurchased $465 million of stock. For 2026, Curtiss-Wright guides to 6%–8% sales growth, adjusted operating margin of 18.9%–19.2%, adjusted EPS of $14.70–$15.15 (up 11%–15%), and free cash flow of $575–$595 million.
Curtiss-Wright director Anthony J. Moraco received an annual equity award of 256 shares of common stock on February 4, 2026. The shares were granted under the company’s 2024 Omnibus Incentive Plan as restricted stock for his service on the board.
The award value was $160,000, calculated using the closing share price of $624.93 on the grant date and rounded down to the nearest whole share. Restrictions lapse after one year or earlier if his board service ends due to death, disability, or failure to be reelected. Following this grant, Moraco directly holds 5,446 shares of Curtiss-Wright common stock.
Curtiss-Wright Corporation director Larry D. Wyche reported an equity grant of restricted common stock. On February 4, 2026, he acquired 128 shares of common stock at a reference price of $624.93 per share under the company’s 2024 Omnibus Incentive Plan.
The award represents half of a $160,000 annual restricted stock grant for non-employee directors, with the number of shares determined by dividing the grant value by the closing price and rounding down. Wyche elected to defer receipt of the remaining 128 shares to a later date. Following this transaction, he beneficially owned 1,514 common shares directly. Restrictions on the granted shares generally lapse after one year or earlier upon death, disability, or failure to be reelected.